SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Seraxis and Sernova Name Patricia Beaston Chief Medical Officer

The companies announced the appointment of former FDA medical officer Dr. Patricia Beaston as chief medical officer of Seraxis and post-merger BetaNova Biotherapeutics. She brings 24 years of FDA leadership experience.

SEOVFSVA